Canada markets closed

Bio-Rad Laboratories, Inc. (BUWA.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
271.10-3.70 (-1.35%)
At close: 08:20AM CEST
Full screen
Previous Close274.80
Open271.10
Bid267.90 x 5000
Ask270.50 x 5000
Day's Range271.10 - 271.10
52 Week Range248.50 - 383.80
Volume8
Avg. Volume2
Market Cap7.57B
Beta (5Y Monthly)0.94
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Bio-Rad Reports First-Quarter 2024 Financial Results

    HERCULES, Calif., May 07, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024.

  • Business Wire

    Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

    HERCULES, Calif., May 01, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Operating Officer Andy Last and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 2:05 PM Eastern Time (11:05 AM Pacific Time).

  • Business Wire

    Bio-Rad Announces Life Science Group Management Changes

    HERCULES, Calif., April 26, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024. He succeeds Dr. Simon May, who has announced his decision to leave the company to pursue another professional opportunity.